Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
0.2950
-0.0080 (-2.64%)
At close: Jun 27, 2025, 4:00 PM
0.2960
+0.0010 (0.34%)
After-hours: Jun 27, 2025, 5:56 PM EDT
Athira Pharma Market Cap
Athira Pharma has a market cap or net worth of $11.52 million as of June 27, 2025. Its market cap has decreased by -88.22% in one year.
Market Cap
11.52M
Enterprise Value
-23.33M
1-Year Change
-88.22%
Ranking
Category
Stock Price
$0.30
Market Cap Chart
Since the IPO on September 18, 2020, Athira Pharma's market cap has decreased from $489.85M to $11.52M, a decrease of -97.65%. That is a compound annual growth rate of -54.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 11.83M | -47.86% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | 1.11B | 127.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.23B |
| Johnson & Johnson | 365.82B |
| AbbVie | 329.86B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.46B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.39B |
| AstraZeneca | 216.45B |